Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma
Clinical trial NCT04065152 · UNKNOWN
Trial details
- NCT number
- NCT04065152
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2023-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.